CLASCOTERONE
| Brand name | WINLEVI |
|---|---|
| Active ingredient | CLASCOTERONE |
| Strength | 1% |
| Dosage form | CREAM |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | August 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9433628 | August 2031 | substance, product |
| 8785427 | July 2030 | product |
| 11207332 | November 2028 | product |
| 10159682 | August 2028 | use U-2942 |
| 12337002 | July 2028 | product |
| 9486458 | July 2028 | use U-2942 |
| 11938141 | July 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.